Avid Bioservices Inc (CDMO)

[cjgaddy]

1st up this morning, I'm listening to the ASTRO/Chicago/Thoracic Preview WEBCAST - I think they're on the 3rd of 4 topics, our Bavi/2ndLine/NSCLC being next. Make sure you click "Listen via Computer" button. After it's over, they say it'll be avail. for a Reply. I'll let you know how it goes - I trust Dr. Gerber himself will give the preview.

1. Fri. Sept7 7:15amCT/8:15amET: ASTRO/Thoracic is putting on a 4-segment “News Briefing #2” Webcast, one segment of which is, “Adding Bavituximab To 2nd-Line Chemotherapy Doubles Response Rate in Late-Stage Lung Cancer Patients”. ***This BRIEFING #2 is not the same as today’s (Sept6) ASTRO/Thoracic Preview “Press Kit” article, ”Adding Bavituximab to 2nd-Line Chemotherapy Doubles Response Rate in Late-Stage Lung Cancer Patients”, which included Dr. Gerber’s plenary ABSTRACT, which stated that Ctl-Arm MOS is 5.4 mos. – see http://tinyurl.com/bwyxf3r . YOU MUST register in advance for the webcast here: https://www.astro.org/News-and-Media/News-Releases/2012/Ground-breaking-research-to-be-presented-at-lung-cancer-symposium.aspx - scroll down to the Sept7 webcast, and click on the GO-TO link. A REPLAY WITH SLIDES will be available after the news briefings here: https://www.astro.org/News-and-Media/Media-Resources/Press-Kits/Thoracic-2012/2012-Thoracic-Symposium-Press-Kit.aspx in the virtual press kit.

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
NEWS BRIEFING #2: Friday, Sept. 7, at 7:15amCT/8:15amET
Study findings previewed:
• Crizotinib [Pfizer’s Xalkori] reduces tumor size in patients with ALK positive lung cancer
• Brain radiation after lung cancer treatment reduces risk of cancer spreading
• Standard chemo treatment provides higher survival rate than experimental regiment in late-stage lung cancer patients
• Adding bavituximab to 2nd-line chemotherapy doubles response rate in late-stage lung cancer patients
REGISTER: https://www.astro.org/News-and-Media/Media-Resources/Press-Kits/Thoracic-2012/2012-Thoracic-Symposium-Press-Kit.aspx